Princeton, NJ and New York, NY - The US FDA has requested more information from Bristol-Myers Squibb and Pfizer for the new anticoagulant apixaban (Eliquis) for the indication of prevention of stroke ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results